Abstract:Purpose To validate the Axillary Reverse Mapping (ARM) technique with indocyanine green (ICG), focusing on the detection rate and the procedure's feasibility. The predictive factors for metastatic involvement of ARM nodes are also analyzed to define the target population for ARM indication. Methods This prospective, observational, non-randomized study of patients with breast cancer included patients with an indication for axillary lymph node dissection (ALND) performed between June 2021 and June 2023. Participants were divided into two cohorts based on pattern of ICG migration: standard technique (all ARM nodes) and targeted technique (in contact with axillary vein). The feasibility of identifying and preserving ARM nodes during ALND was assessed. Multivariate logistic regression was used to analyze predictive factors (e.g., tumor size, molecular surrogate subtype, multifocality, and neoadjuvant therapy) for metastatic ARM nodes. Results Of the 41 patients in whom we performed the ARM technique, ARM nodes were identified and preserved after ALND in 36 patients (87.8%). Of these, 17 (89.5%) underwent the standard technique and 19 (86.4%) underwent the targeted technique. ARM metastases were identified in 12 patients: 9 (47.1%) with the standard technique and 3 (15.7%) with the targeted technique (p = 0.026). The ARM technique was the only risk factor for ARM involvement (odds ratio, 15.9; 95% confidence interval, 1.1– 218.6). Conclusions ICG facilitates the successful completion of ARM in almost 90% of patients undergoing ALND. In addition, by selecting the ARM nodes closest to the axillary vein, the number of cross metastases can be significantly reduced. MICRO Background and Objectives Axillary Reverse Mapping (ARM) with indocyanine green (ICG) aims to validate detection rates, feasibility, and predictive factors for metastatic involvement to define its target population. Methods A prospective study of 41 breast cancer patients undergoing axillary lymph node dissection (ALND), comparing standard and targeted ARM techniques based on ICG migration patterns. Results ARM nodes were identified and preserved in 87.8% of patients. Metastases were significantly lower with the targeted technique (15.7%) compared to the standard technique (47.1%, p = 0.026). Conclusions ARM with ICG is feasible and effective, reducing cross metastases by selecting ARM nodes near the axillary vein.

Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.

A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

Axillary reverse mapping by dye method in 300 breast cancer patients

Safety Study of Axillary Reverse Mapping in the Surgical Treatment for Breast Cancer Patients

Clinical application of axillary reverse mapping in breast cancer patients undergoing axillary lymph node dissection

The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial

Relationship Between Upper Extremity Lymphatic Drainage and Sentinel Lymph Nodes in Patients with Breast Cancer

Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial

Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow

Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for Lymphedema Prevention after Axillary Lymph Node Dissection—A Single Institution Experience and Feasibility of Technique

Axillary reverse mapping using indocyanine green in breast cancer: Standardization of the technique

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection

Is axillary reverse mapping in patients with breast cancer oncologically safe?

Collateralization of the upper extremity lymphatic system after axillary lymph node dissection

Prophylactic Buried Dermal Flap: A Simple Method for Axillary Reconstruction after Lymph Node Dissection

Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis

The feasibility of targeted axillary dissection for breast cancer axillary surgery de-escalation after neoadjuvant therapy: A prospective cohort study

The long-term safety of sentinel lymph node biopsy mapped by combination of indocyanine green and methylene blue in breast cancer patients

Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial

Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study